BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hepatitis
,
Heart
,
Laser capture microdissection
,
Lovastatin
,
rs6983267
,
SIRT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ATXN1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Putamen
Caudate
Endometrium
T Lymphocyte (regulatory) of peripheral blood
Frontal lobe
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Spinocerebellar ataxia
Pyloric ulcer
Encephalomyelopathy
Vesicular stomatitis Indiana virus disease
Shock
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
nitidine chloride
Ethyl Methanesulfonate
Organophosphorus Compounds
Bupivacaine
granulin precursor protein
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PCSK9
KLHL6
STUB1
USP7
NPAT
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Mapping SCA1 regional vulnerabilities reveals neural and skeletal muscle contributions to disease.
Cerebellar Heterogeneity and Selective vulnerability in Spinocerebellar Ataxia Type 1 (SCA1).
Expanded ATXN1 alters transcription and calcium signaling in SCA1 human motor neurons differentiated…
Generation of induced pluripotent stem cell(iPSC)line CJUHi001-A derived peripheral blood mononuclea…
Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spin…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL)
Clinical Trial Readiness for SCA1 and SCA3
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ